175 related articles for article (PubMed ID: 35645577)
1. A Nomogram Model for Predicting Recurrence of Stage I-III Endometrial Cancer Based on Inflammation-Immunity-Nutrition Score (IINS) and Traditional Classical Predictors.
Jiang P; Wang J; Gong C; Yi Q; Zhu M; Hu Z
J Inflamm Res; 2022; 15():3021-3037. PubMed ID: 35645577
[TBL] [Abstract][Full Text] [Related]
2. The prognostic significance of inflammation-immunity-nutrition score on postoperative survival and recurrence in hepatocellular carcinoma patients.
Liang Y; Zhang Z; Zhong D; Lai C; Dai Z; Zou H; Feng T; Shang J; Shi Y; Huang X
Front Oncol; 2022; 12():913731. PubMed ID: 36016629
[TBL] [Abstract][Full Text] [Related]
3. A Nomogram Model Involving Immunohistochemical Markers for Predicting the Recurrence of Stage I-II Endometrial Cancer.
Jiang P; Jia M; Hu J; Huang Z; Deng Y; Hu Z
Front Oncol; 2020; 10():586081. PubMed ID: 33585205
[TBL] [Abstract][Full Text] [Related]
4. Predicting Recurrence in Endometrial Cancer Based on a Combination of Classical Parameters and Immunohistochemical Markers.
Jiang P; Huang J; Deng Y; Hu J; Huang Z; Jia M; Long J; Hu Z
Cancer Manag Res; 2020; 12():7395-7403. PubMed ID: 32922070
[TBL] [Abstract][Full Text] [Related]
5. Combining Clinicopathological Parameters and Molecular Indicators to Predict Lymph Node Metastasis in Endometrioid Type Endometrial Adenocarcinoma.
Jiang P; Huang Y; Tu Y; Li N; Kong W; Di F; Jiang S; Zhang J; Yi Q; Yuan R
Front Oncol; 2021; 11():682925. PubMed ID: 34422634
[TBL] [Abstract][Full Text] [Related]
6. A Nomogram Model Based on the Inflammation-Immunity-Nutrition Score (IINS) and Classic Clinical Indicators for Predicting Prognosis in Extranodal Natural Killer/T-Cell Lymphoma.
He Y; Luo Z; Chen H; Ping L; Huang C; Gao Y; Huang H
J Inflamm Res; 2024; 17():2089-2102. PubMed ID: 38595337
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Value of Inflammation-Immunity-Nutrition Score and Inflammatory Burden Index for Hepatocellular Carcinoma Patients After Hepatectomy.
Song R; Ni H; Huang J; Yang C; Qin S; Wei H; Luo J; Huang Y; Xiang B
J Inflamm Res; 2022; 15():6463-6479. PubMed ID: 36467989
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of inflammation-immunity-nutrition score in patients with hepatocellular carcinoma treated with anti-PD-1 therapy.
Zhang Z; Liang Y; Zhong D; Dai Z; Shang J; Lai C; Zou H; Yao Y; Feng T; Huang X
J Clin Lab Anal; 2022 May; 36(5):e24336. PubMed ID: 35312116
[TBL] [Abstract][Full Text] [Related]
9. Prognostic prediction by a novel integrative inflammatory and nutritional score based on least absolute shrinkage and selection operator in esophageal squamous cell carcinoma.
Feng J; Wang L; Yang X; Chen Q; Cheng X
Front Nutr; 2022; 9():966518. PubMed ID: 36438741
[TBL] [Abstract][Full Text] [Related]
10. A Novel Hematological Inflammation-Nutrition Score (HINS) and Its Related Nomogram Model to Predict Survival Outcome in Advanced Gastric Cancer Patients Receiving First-Line Palliative Chemotherapy.
Chen C; Wang Z; Qin Y
J Inflamm Res; 2023; 16():2929-2946. PubMed ID: 37465343
[TBL] [Abstract][Full Text] [Related]
11. A prediction model based on clinical and histological features for predicting recurrence in patients with stage I-II endometrial cancer after surgical treatment.
Song W; Zhao Y
Ann Diagn Pathol; 2022 Feb; 56():151861. PubMed ID: 34953233
[TBL] [Abstract][Full Text] [Related]
12. Predicting the Recurrence of Operable Cervical Cancer Patients Based on Hemoglobin, Albumin, Lymphocyte, and Platelet (HALP) Score and Classical Clinicopathological Parameters.
Jiang P; Kong W; Gong C; Chen Y; Li F; Xu L; Yang Y; Gou S; Hu Z
J Inflamm Res; 2022; 15():5265-5281. PubMed ID: 36120183
[TBL] [Abstract][Full Text] [Related]
13. Metabolic risk score as a predictor in a nomogram for assessing myometrial invasion for endometrial cancer.
Qiang Y; Zhang Q; Dong L
Oncol Lett; 2023 Mar; 25(3):114. PubMed ID: 36844632
[TBL] [Abstract][Full Text] [Related]
14. A Nomogram Model to Predict Recurrence of Non-Muscle Invasive Bladder Urothelial Carcinoma After Resection Based on Clinical Parameters and Immunohistochemical Markers.
Pi J; Xiong Y; Liu C; Liao J; Liu J; Li C; Fu W; Zhao T
J Invest Surg; 2022 May; 35(5):1186-1194. PubMed ID: 34913802
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of a nomogram involving immunohistochemical markers for prediction of recurrence in early low-risk endometrial cancer.
Kong W; Tu Y; Jiang P; Huang Y; Zhang J; Jiang S; Li N; Yuan R
Int J Biol Markers; 2022 Dec; 37(4):395-403. PubMed ID: 36250543
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of a prognostic model based on metabolic risk score to predict overall survival of endometrial cancer in Chinese patients.
Li X; Yang X; Cheng Y; Dong Y; Wang J; Wang J
J Gynecol Oncol; 2023 Nov; 34(6):e69. PubMed ID: 37293802
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of a nomogram for predicting recurrence-free survival in endometrial cancer: a multicenter study.
Li Y; Hou X; Chen W; Wang S; Ma X
Sci Rep; 2023 Nov; 13(1):20270. PubMed ID: 37985680
[TBL] [Abstract][Full Text] [Related]
18. Pathologic Complete Response Prediction to Neoadjuvant Immunotherapy Combined with Chemotherapy in Resectable Locally Advanced Esophageal Squamous Cell Carcinoma: Real-World Evidence from Integrative Inflammatory and Nutritional Scores.
Feng J; Wang L; Yang X; Chen Q; Cheng X
J Inflamm Res; 2022; 15():3783-3796. PubMed ID: 35832830
[TBL] [Abstract][Full Text] [Related]
19. A Prognostic Nomogram and Heat Map to Predict Survival in Stage II/III Gastric Cancer Patients After Curative Gastrectomy Followed by Adjuvant Chemotherapy.
Shi L; Wang Z; Wang L; Jia Y; Li J; Qin Y
Cancer Manag Res; 2022; 14():287-301. PubMed ID: 35115828
[TBL] [Abstract][Full Text] [Related]
20. Nomogram Based on Systemic Immune Inflammation Index and Prognostic Nutrition Index Predicts Recurrence of Hepatocellular Carcinoma After Surgery.
Yang J; Bao Y; Chen W; Duan Y; Sun D
Front Oncol; 2020; 10():551668. PubMed ID: 33163397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
